Direkt zum Inhalt
Merck

Management of chronic Achilles tendinopathy.

Drug and therapeutics bulletin (2012-08-10)
ZUSAMMENFASSUNG

Tendons transmit force between muscles and bones and, when stretched, store elastic energy that contributes to movement.(1) The tendinous portion of the gastrocnemius and soleus muscles merge to form the Achilles tendon, which is the largest and strongest in the body, but one of the most frequently injured.(2,3) Conservative management options for chronic Achilles tendinopathy include eccentric (lengthening) exercises, extracorporeal shockwave therapy (ESWT), topical nitroglycerin, low level laser therapy, orthoses, splints or injections (e.g. corticosteroids, hyperosmolar dextrose, polidocanol, platelet-rich plasma), while a minority of patients require surgery (using open, percutaneous or endoscopic methods).(4-8) Here we assess the management options for patients with chronic Achilles tendinopathy (lasting over 6 weeks).

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Decaethylenglykolmonododecylether, nonionic surfactant
Sigma-Aldrich
Thesit®, for membrane research
Sigma-Aldrich
Brij® L23 -Lösung, 30 % (w/v) in H2O
Sigma-Aldrich
Brij® L23, main component: tricosaethylene glycol dodecyl ether
Sigma-Aldrich
Brij® L4, average Mn ~362
Sigma-Aldrich
Brij® L23, suitable for Stein-Moore chromatography
Sigma-Aldrich
ECO BRIJ® L4, average Mn ~362
Sigma-Aldrich
ECO Brij® L23